Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 7/20 | 0.51 |
| ▸ | CPN1 | P15169 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6493022 | 0.86 | AOC3 (0.51) | AOC3CPN1CPB2TAAR1MEN1 | |
| SCHEMBL6491739 | 0.83 | HIF1A (0.56) | AOC3TAAR1MEN1KMT2ASLC6A3 | |
| SCHEMBL6284970 | 0.81 | AOC3 (0.68) | AOC3TAAR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL6282438 | 0.79 | AOC3 (0.73) | AOC3L3MBTL1SLC6A2SLC6A4 | |
| SCHEMBL7654348 | 0.76 | LMNA (0.59) | AOC3CPN1CPB2L3MBTL1SLC6A2 | |
| SCHEMBL5466349 | 0.76 | LMNA (0.59) | AOC3CPN1CPB2L3MBTL1SLC6A2 | |
| SCHEMBL5466344 | 0.76 | LMNA (0.59) | AOC3CPN1CPB2L3MBTL1SLC6A2 | |
| SCHEMBL1356331 | 0.76 | CPN1 (0.42) | AOC3CPN1CPB2MEN1HPGD | |
| SCHEMBL6318818 | 0.74 | POLB (0.47) | MEN1KMT2AL3MBTL1SLC6A2SLC6A4 | |
| SCHEMBL2238144 | 0.74 | CPN1 (0.49) | AOC3CPN1CPB2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861438-B2 | Antiviral agents | PFIZER (US) | 2005-03-01 | — | — | US | claimed |
| US-20040138449-A1 | Antiviral agents | PHARMACIA & UPJOHN COMPANY | 2004-07-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138449-A1 | Antiviral agents | IRF3, IFNAR1, EIF2AK2 | AOC3 4495/4885CPN1 1491/4885CPB2 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.